Renaissance Technologies Portfolio holdings
Renaissance Technologies is a hedge fund firm that trades with computer models built on mathematics and statistics. It began in 1978 as Monemetrics, founded by Jim Simons, a mathematician and former Cold War codebreaker, and took its current name in 1982. The firm launched its Medallion Fund in 1988 and staffs its research with mathematicians, statisticians, physicists, astronomers and computer scientists. Medallion trades over short time spans across many asset types, and it has been closed to outside investors since 1993, open only to current and past employees and their families.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$814M |
| 2 |
NVIDIA
NVDA
|
+$448M |
| 3 |
Microsoft
MSFT
|
+$394M |
| 4 |
Apple
AAPL
|
+$368M |
| 5 |
Johnson & Johnson
JNJ
|
+$288M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$616M |
| 2 |
Tesla
TSLA
|
+$406M |
| 3 |
Palo Alto Networks
PANW
|
+$400M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$394M |
| 5 |
AT&T
T
|
+$389M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.33% |
| 2 | Technology | 19.75% |
| 3 | Consumer Staples | 10.6% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Communication Services | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$179B
| $2.03B | 2.53% |
48,362,142
-1,331,200
| -3% | -$51.6M |
2013 Q2
32 quarters
|
|
2
VeriSign
VRSN
$28.3B
| $1.1B | 1.38% |
4,841,290
-27,024
| -0.6% | -$5.88M |
2013 Q2
32 quarters
|
|
3
Zoom
ZM
$28.3B
| $1.03B | 1.29% |
2,662,863
+142,000
| +6% | +$47.3M |
2020 Q1
5 quarters
|
|
|
4
NVIDIA
NVDA
$4.26T
| $929M | 1.16% |
46,431,720
+27,940,000
| +151% | +$448M |
2020 Q4
2 quarters
|
|
|
5
Amazon
AMZN
$2.88T
| $897M | 1.12% |
5,213,100
+4,896,000
| +1,544% | +$814M |
2020 Q3
3 quarters
|
|
6
Target
TGT
$73.9B
| $870M | 1.09% |
3,600,559
+14,500
| +0.4% | +$3.17M |
2019 Q1
9 quarters
|
|
7
Atlassian
TEAM
$38.4B
| $846M | 1.06% |
3,293,360
-48,060
| -1% | -$11.3M |
2016 Q2
20 quarters
|
|
8
Moderna
MRNA
$100B
| $749M | 0.94% |
3,188,454
+1,552,925
| +95% | +$278M |
2020 Q4
2 quarters
|
|
9
Kroger
KR
$40.4B
| $679M | 0.85% |
17,731,571
+557,500
| +3% | +$21M |
2019 Q2
8 quarters
|
|
10
Monster Beverage
MNST
$88.8B
| $656M | 0.82% |
28,710,240
-3,116,800
| -10% | -$73.1M |
2014 Q1
29 quarters
|
|
11
Franco-Nevada
FNV
$49B
| $634M | 0.79% |
4,369,790
-467,600
| -10% | -$67.7M |
2014 Q1
29 quarters
|
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
| $578M | 0.72% |
3,147,521
-180,600
| -5% | -$31M |
2018 Q3
11 quarters
|
|
13
Domino's
DPZ
$10.7B
| $573M | 0.72% |
1,228,025
+291,600
| +31% | +$124M |
2013 Q2
32 quarters
|
|
14
Molina Healthcare
MOH
$10.9B
| $569M | 0.71% |
2,248,465
-217,950
| -9% | -$54.8M |
2013 Q2
32 quarters
|
|
|
15
Microsoft
MSFT
$3.87T
| $561M | 0.7% |
2,069,184
+1,549,000
| +298% | +$394M |
2020 Q3
3 quarters
|
|
|
16
Apple
AAPL
$5.16T
| $559M | 0.7% |
4,078,632
+2,841,100
| +230% | +$368M |
2020 Q3
3 quarters
|
|
17
United Therapeutics
UTHR
$25.3B
| $558M | 0.7% |
3,110,191
-97,400
| -3% | -$18.6M |
2013 Q2
32 quarters
|
|
18
Hershey
HSY
$35B
| $556M | 0.69% |
3,192,466
-168,795
| -5% | -$28.4M |
2013 Q2
32 quarters
|
|
|
ABMD
19
DELISTED
Abiomed Inc
ABMD
| $524M | 0.65% |
1,678,923
-101,200
| -6% | -$31M |
2015 Q1
25 quarters
|
|
20
Vodafone
VOD
$36.1B
| $511M | 0.64% |
29,809,976
-2,500,100
| -8% | -$46.8M |
2015 Q3
23 quarters
|
|
21
Bristol-Myers Squibb
BMY
$127B
| $488M | 0.61% |
7,305,925
+333,738
| +5% | +$21.8M |
2016 Q2
20 quarters
|
|
22
Alphabet (Google) Class A
GOOGL
$3.62T
| $483M | 0.6% |
3,956,960
-330,000
| -8% | -$38.5M |
2018 Q3
11 quarters
|
|
23
Herbalife
HLF
$1.61B
| $469M | 0.59% |
8,894,664
-140,100
| -2% | -$6.97M |
2015 Q3
23 quarters
|
|
24
Biogen
BIIB
$37.4B
| $461M | 0.57% |
1,330,003
-608,159
| -31% | -$184M |
2018 Q1
13 quarters
|
|
25
Vertex Pharmaceuticals
VRTX
$137B
| $459M | 0.57% |
2,277,284
-123,000
| -5% | -$25.7M |
2017 Q1
17 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2021 Portfolio in Review
As of Q2 2021, Renaissance Technologies held 3,960 positions worth $80.1B, down 0.34% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.64B in Q2 2021, closing 551 positions and reducing 1,699 holdings. Its most notable exit was AT&T, an estimated $389M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Caterpillar worth $227M.
- Renaissance Technologies's largest Q2 2021 buy was Caterpillar: 1,042,778 shares worth $227M.
- Renaissance Technologies added most to Amazon in Q2 2021, an estimated $814M increase.
- Renaissance Technologies's biggest Q2 2021 reduction was Baidu, cutting an estimated $616M.
- Renaissance Technologies fully exited AT&T in Q2 2021, selling an estimated $389M.
- Renaissance Technologies's ten largest holdings make up 12% of its $80.1B portfolio in Q2 2021.
- Renaissance Technologies opened 700 new positions and closed 551 in Q2 2021.
- Renaissance Technologies's portfolio value fell 0.34% quarter-over-quarter to $80.1B.
Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.